Health - Arthritis latest news

Following the widespread media coverage regarding the NICE FAD on the sequencing of anti-TNF inhibitors, Roche want to reassure patients with rheumatoid arthritis and rheumatology health professionals that they will continue to benefit from access to effective treatment with MabThera (rituximab), following the use of one anti-TNF, for this debilitating disease.

Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB). Lead author Kenneth Saag, M.D., M.Sc.